RN765C, a low affinity EGFR antibody drug conjugate with potent anti-tumor activity in preclinical solid tumor models

por Wong, Oi Kwan, Tran, Thomas-Toan, Ho, Wei-Hsien, Casas, Meritxell Galindo, Au, Melinda, Bateman, Marjorie, Lindquist, Kevin C., Rajpal, Arvind, Shelton, David L., Strop, Pavel, Liu, Shu-Hui
Publicado 2018

Optimal design, anti-tumour efficacy and tolerability of anti-CXCR4 antibody drug conjugates

por Costa, Maria José, Kudaravalli, Jyothirmayee, Ma, Jing-Tyan, Ho, Wei-Hsien, Delaria, Kathy, Holz, Charles, Stauffer, Angela, Chunyk, Allison Given, Zong, Qing, Blasi, Eileen, Buetow, Bernard, Tran, Thomas-Toan, Lindquist, Kevin, Dorywalska, Magdalena, Rajpal, Arvind, Shelton, David L., Strop, Pavel, Liu, Shu-Hui
Publicado 2019